Helix

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

You can watch Helix and buy or sell other stocks, options, and ETFs commission-free!

About HLXA

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. 

CEO
Jorge Santos da Silva, PhD
CEOJorge Santos da Silva, PhD
Employees
2
Employees2
Headquarters
Zug, Zug
HeadquartersZug, Zug
Founded
2021
Founded2021
Employees
2
Employees2

HLXA Key Statistics

Market cap
489.26M
Market cap489.26M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
36.29K
Average volume36.29K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$15.19
52 Week high$15.19
52 Week low
$4.25
52 Week low$4.25
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.